Joint Statement from the UK Space Agency, the Medicines and Healthcare products Regulatory Agency, the Regulatory Innovation Office and the Civil Aviation Authority

As with any medicine, the MHRA will keep the safety and effectiveness of Nirogacestat hydrobromide under close review.

Parallel import licences granted in 2025.

New Moderna Innovation and Technology Centre opened as government further boosts life sciences sector with £50 million fund.

Summary of the latest safety advice for medicines and medical device users

WHO recognition affirms MHRA’s commitment to regulatory excellence, innovation and global collaboration

How to show the MHRA you’re meeting good clinical practice (GCP) standards and what to expect from an inspection.